Attention deficit hyperactivity disorder, Borderline personality disorder research hub

A study to test how BI 3031185 is tolerated by people with borderline personality disorder or attention-deficit/hyperactivity disorder.

This early-stage clinical trial looks at how well adults with ADHD or borderline personality disorder tolerate a new medicine called BI 3031185. Researchers want to check safety, monitor for potential side effects, and understand how the body processes the drug to help guide future treatment options.